Description

({5-[(4-Chlorophenoxy)Methyl]-1,3,4-Thiadiazol-2-Yl}Amino)(Oxo)Acetic Acid is a high-purity, synthetically derived organic compound featuring a 1,3,4-thiadiazole core functionalized with chlorophenoxy and oxoacetic acid moieties. This specific molecular architecture makes it a valuable advanced pharmaceutical intermediate and a versatile building block for research and development in medicinal chemistry. It is primarily sought by pharmaceutical manufacturers and contract research organizations (CROs) engaged in the synthesis of novel active pharmaceutical ingredients (APIs) and agrochemicals.

Application

• Pharmaceutical Intermediate: A key synthetic precursor in the development of new drug candidates, particularly those targeting infectious diseases or metabolic disorders.
• Agrochemical Research: Serves as a core scaffold for synthesizing novel herbicides, fungicides, or plant growth regulators, leveraging the bioactivity of the thiadiazole and chlorophenoxy groups.
• Medicinal Chemistry Building Block: Used in high-throughput screening and structure-activity relationship (SAR) studies to explore new therapeutic avenues.
• Chemical Synthesis Reagent: Employed in organic synthesis for the construction of complex heterocyclic compounds in academic and industrial R&D settings.
• Bioconjugate Chemistry: The reactive functional groups allow for potential use in creating targeted drug delivery systems or diagnostic probes.

Basic Information

Product Name	({5-[(4-Chlorophenoxy)Methyl]-1,3,4-Thiadiazol-2-Yl}Amino)(Oxo)Acetic Acid
CAS No.	931374-35-5
Molecular Formula	C11H8ClN3O4S
Molecular Weight	313.71 g/mol
Synonyms	2-({5-[(4-Chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl}amino)-2-oxoacetic acid; Oxo({5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl}amino)acetic acid; 2-((5-((4-Chlorophenoxy)methyl)-1,3,4-thiadiazol-2-yl)amino)-2-oxoacetic acid; (5-((4-Chlorophenoxy)methyl)-1,3,4-thiadiazol-2-yl)carbamoylformic acid; Glyoxylic acid, 2-((5-((4-chlorophenoxy)methyl)-1,3,4-thiadiazol-2-yl)amino)-2-oxo-; 931374-35-5
EINECS	Contact for details

Quality Control

Our production of ({5-[(4-Chlorophenoxy)Methyl]-1,3,4-Thiadiazol-2-Yl}Amino)(Oxo)Acetic Acid adheres to stringent quality management protocols. Every batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and IR for structural confirmation, and residual solvent analysis. Certificates of Analysis (COA) detailing all specifications are provided to ensure full traceability and compliance with your research or cGMP-grade requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept under inert atmosphere or in a desiccator after opening to prevent degradation.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.